Cargando…
Early disease progression of Hurler syndrome
BACKGROUND: Newborn screening for mucopolysaccharidosis type I (MPS I) shows promise to improve outcomes by facilitating early diagnosis and treatment. However, diagnostic tests for MPS I are of limited value in predicting whether a child will develop severe central nervous system disease associated...
Autores principales: | Kiely, Bridget T., Kohler, Jennifer L., Coletti, Hannah Y., Poe, Michele D., Escolar, Maria L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307824/ https://www.ncbi.nlm.nih.gov/pubmed/28193245 http://dx.doi.org/10.1186/s13023-017-0583-7 |
Ejemplares similares
-
The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK
por: Moore, David, et al.
Publicado: (2008) -
Heart valve disease in Hurler-Scheie syndrome
por: del Carmen García del Rey, María, et al.
Publicado: (2022) -
Hurler Syndrome: Orofacial Clinical Findings
por: Rodrigues Barros, Cristina, et al.
Publicado: (2023) -
Management of an anticipated difficult airway in Hurler's syndrome
por: Gurumurthy, T., et al.
Publicado: (2014) -
Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months
por: Beltran-Quintero, Maria L., et al.
Publicado: (2019)